USPTO Patent Application for Lactation Reduction Compounds

The United States Patent and Trademark Office (USPTO) has published a patent application, identified as US20260083687A1, detailing compounds for reducing lactation and improving health. The application, filed on April 14, 2023, lists specific chemical compounds including various disulfides, sulfides, trisulfides, sulfones, thiosulfinates, and thiosulfonates as preferred embodiments. This filing is a request for patent protection and does not impose regulatory obligations on any entity.

While this is a patent application and not a regulatory requirement, entities involved in pharmaceutical research and development, particularly those working on compounds related to lactation or reproductive health, should be aware of this filing. It may indicate potential future intellectual property claims or new areas of research and development in the pharmaceutical sector. No immediate compliance actions are required based on this patent application.